Who invested in Alpine Immune Sciences?
Alpine Immune Sciences's investors include OrbiMed, TCG, Omega Funds, Samsara BioCapital and TCG Crossover.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$199Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Jan 2015
From the SEC filings it signed: 4 on the team.
On the board, as filediChristopher Paul PeetzCui Paul XiangminJames Paul TopperJay Paul VenkatesanNatasha Paul HerndayPeter Paul ThompsonRobert Paul Conway
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alpine Immune Sciences's investors include OrbiMed, TCG, Omega Funds, Samsara BioCapital and TCG Crossover.
Alpine Immune Sciences has raised $199M across 3 rounds since 2015.
Alpine Immune Sciences's most recent round was an Undisclosed round of $150M in Nov 2023.
Its most recent round, $150M in Nov 2023, is also its largest on record.
Alpine Immune Sciences's first round on record, in Jun 2016, was backed by OrbiMed.
Alpine Immune Sciences's latest named round is an Undisclosed round, in Nov 2023.
Alpine Immune Sciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.